311. Expansion of Gene-Modified T Cells Following Direct Intravenous Injection of Therapeutic Foamy Virus Vector in a Canine Model of Severe Combined Immunodeficiency

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34646-9
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Virus-Specific Immunity After Gene Therapy in a Murine Model of Severe Combined Immunodeficiency

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

284. Long-Term Therapeutic Immune Reconstitution in XSCID Canine Model via in Vivo Foamy Virus Delivery of Common Gamma Chain

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Distribution Volumes of T-1824 and Chromium51 Labelled Red Cells Immediately Following Intravenous Injection

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1957English

Mutations in Linker for Activation of T Cells (LAT) Lead to a Novel Form of Severe Combined Immunodeficiency

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Diagnosis of Severe Combined Immunodeficiency

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2001English

Direct Expansion of Human Allospecific FoxP3+CD4+ Regulatory T Cells With Allogeneic B Cells for Therapeutic Application

Journal of Immunology
AllergyImmunology
2009English

T-B Severe Combined Immunodeficiency Due to JAK3 Deficiency

2020English

Transgenerational Transfer of Gene-Modified T Cells

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Beyond Help: Direct Effector Functions of Human Immunodeficiency Virus Type 1-Specific CD4+ T Cells

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy